FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald Calne

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Pedigree

Co-author Network

Publications

TOP 3
Raúl de La Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
R Nandhagopal; Lisa Kuramoto; Michael Schulzer; Edwin Mak; J Cragg; Chong S Lee; J McKenzie; S McCormick; Ali Samii; André R Troiano; Thomas J Ruth; Vesna Sossi; Raul de la Fuente-Fernandez; Donald B Calne; A Jon Stoessl
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
Yulia Golub; Daniela Berg; Donald B Calne; Ronald F Pfeiffer; Ryan Uitti; A Jon Stoessl; Zbigniew K Wszolek; Matthew J Farrer; Jakob C Mueller; Thomas Gasser; Julia Fuchs
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald Calne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Raúl de La Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Annals of neurology 2011;69(5):803-10.
2009: R Nandhagopal; Lisa Kuramoto; Michael Schulzer; Edwin Mak; J Cragg; Chong S Lee; J McKenzie; S McCormick; Ali Samii; André R Troiano; Thomas J Ruth; Vesna Sossi; Raul de la Fuente-Fernandez; Donald B Calne; A Jon Stoessl
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
Brain : a journal of neurology 2009;132(Pt 11):2970-9.
2009: Yulia Golub; Daniela Berg; Donald B Calne; Ronald F Pfeiffer; Ryan Uitti; A Jon Stoessl; Zbigniew K Wszolek; Matthew J Farrer; Jakob C Mueller; Thomas Gasser; Julia Fuchs
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.
Parkinsonism & related disorders 2009;15(7):539-41.
2009: Christian Wider; dennis dickson; A Jon Stoessl; Yoshio Tsuboi; Françoise Chapon; Ludwig Gutmann; Bernard Lechevalier; Donald B Calne; David A Personett; Mary Hulihan; Jennifer Kachergus; Rosa Rademakers; Matthew C Baker; Linda L Grantier; O K Sujith; Laura Brown; Susan M Calne; Matthew J Farrer; Zbigniew K Wszolek
Pallidonigral TDP-43 pathology in Perry syndrome.
Parkinsonism & related disorders 2009;15(4):281-6.
2009: Matthew J Farrer; Mary Hulihan; Jennifer Kachergus; Justus C Dächsel; A Jon Stoessl; Linda L Grantier; Susan M Calne; Donald B Calne; Bernard Lechevalier; Francoise Chapon; Yoshio Tsuboi; Tatsuo Yamada; Ludwig Gutmann; Bülent Elibol; Kailash P Bhatia; Christian Wider; Carles vilarino-guell; Owen A Ross; Laura A Brown; Monica Castanedes-Casey; dennis dickson; Zbigniew K Wszolek
DCTN1 mutations in Perry syndrome.
Nature genetics 2009;41(2):163-5.
2007: Judith Miklossy; Hong Qing; Jian-Ping Guo; Sheng Yu; Zbigniew K Wszolek; Donald B Calne; Edith G McGeer; Patrick L McGeer
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.
Acta neuropathologica 2007;114(3):243-54.
2007: Stacey Melquist; David Craig; Matthew Huentelman; Richard Crook; John Pearson; Matt Baker; Victoria L Zismann; Jennifer Gass; Jennifer Adamson; Szabolcs Szelinger; Jason Corneveaux; Ashley Cannon; Keith D Coon; Sarah J Lincoln; Charles H Adler; Paul Tuite; Donald B Calne; Eileen H Bigio; Ryan Uitti; Zbigniew K Wszolek; Lawrence I Golbe; Richard Caselli; Neill R Graff-Radford; Irene Litvan; Matthew J Farrer; dennis dickson; Michael Hutton; Dietrich A Stephan
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.
American journal of human genetics 2007;80(4):769-78.
2007: Chin-Chang Huang; Nai-Shin Chu; Chin-Song Lu; Rou-Shayn Chen; M Schulzer; Donald B Calne
The natural history of neurological manganism over 18 years.
Parkinsonism & related disorders 2007;13(3):143-5.
2006: Zbigniew K Wszolek; Yasuhiko Baba; Ian R A Mackenzie; Ryan Uitti; Audrey Strongosky; Daniel F Broderick; Matthew C Baker; Stacey Melquist; Michael Hutton; Yoshio Tsuboi; J E Allanson; J Carr; A Kumar; Susan M Calne; Judith Miklossy; Patrick L McGeer; Donald B Calne; A Jon Stoessl
Autosomal dominant dystonia-plus with cerebral calcifications.
Neurology 2006;67(4):620-5.
2005: John R Adams; Hinke van Netten; Michael Schulzer; Edwin Mak; Jessamyn Mckenzie; Audrey Strongosky; Vesna Sossi; Thomas J Ruth; Chong S Lee; Matthew J Farrer; Thomas Gasser; Ryan Uitti; Donald B Calne; Zbigniew K Wszolek; A Jon Stoessl
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Brain : a journal of neurology 2005;128(Pt 12):2777-85.
2005: Wing Lok Au; Donald B Calne
A reassessment of the Lewy body.
Acta neurologica Taiwanica 2005;14(2):40-7.
2005: Judith Miklossy; Ian R A Mackenzie; Katerina Dorovini-Zis; Donald B Calne; Zbigniew K Wszolek; Andis Klegeris; Patrick L McGeer
Severe vascular disturbance in a case of familial brain calcinosis.
Acta neuropathologica 2005;109(6):643-53.
2005: Donald B Calne
A definition of Parkinson's disease.
Parkinsonism & related disorders 2005;11 Suppl 1():S39-40.
2005: Donald B Calne; Michael Schulzer; Edwin Mak; A Jon Stoessl
Treatment for the progression of Parkinson's disease.
Lancet neurology 2005;4(4):206.
2004: J R M Oliveira; Elizabeth Spiteri; Maria-Jesús Sobrido; S Hopfer; J Klepper; T Voit; John Gilbert; Zbigniew K Wszolek; Donald B Calne; A Jon Stoessl; Michael Hutton; B V Manyam; François Boller; M Baquero; Daniel Geschwind
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).
Neurology 2004;63(11):2165-7.
2004: Chong S Lee; Michael Schulzer; Raúl de La Fuente-Fernández; Edwin Mak; Lisa Kuramoto; Vesna Sossi; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Archives of neurology 2004;61(12):1920-5.
2004: Ryan Uitti; Donald B Calne; dennis dickson; Zbigniew K Wszolek
Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder.
Parkinsonism & related disorders 2004;10(8):461-3.
2004: Raúl de La Fuente-Fernández; Vesna Sossi; Zhigao Huang; Sarah Furtado; Jian-Qiang Lu; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Brain : a journal of neurology 2004;127(Pt 12):2747-54.
2004: Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew J Farrer; Sarah J Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; dennis dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron 2004;44(4):601-7.
2004: John R Adams; André R Troiano; Donald B Calne
Functional imaging in Tourette's syndrome.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1495-506.
2004: Peter Riederer; E Hirsch; Moussa B H Youdim; Donald B Calne
A tribute for Prof. Dr. Melvin D. Yahr, M.D. (1917-2004).
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1205-8.
2004: Ajit Kumar; Susan M Calne; Michael Schulzer; Edwin Mak; Zbigniew K Wszolek; Chris van Netten; Joseph K C Tsui; A Jon Stoessl; Donald B Calne
Clustering of Parkinson disease: shared cause or coincidence?
Archives of neurology 2004;61(7):1057-60.
2004: Donald B Calne; Yoshikuni Mizuno
The neuromythology of Parkinson's Disease.
Parkinsonism & related disorders 2004;10(5):319-22.
2004: Sarah Furtado; Haydeh Payami; Paul J Lockhart; Melissa Hanson; John G Nutt; Amanda Adam Singleton; Amanda Singleton; Jamel Bower; Ryan J Utti; Thomas D Bird; Raul de la Fuente-Fernandez; Yoshio Tsuboi; Mary L Klimek; Oksana Suchowersky; John Hardy; Donald B Calne; Zbigniew K Wszolek; Matthew J Farrer; Katrina Gwinn-Hardy; A Jon Stoessl
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):622-9.
2004: Zbigniew K Wszolek; Ronald F Pfeiffer; Yoshio Tsuboi; Ryan Uitti; Rodney D McComb; A Jon Stoessl; Audrey Strongosky; Alexander Zimprich; Bertram Müller-Myhsok; Matthew J Farrer; Thomas Gasser; Donald B Calne; dennis dickson
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.
Neurology 2004;62(9):1619-22.
2004: Raúl de La Fuente-Fernández; Michael Schulzer; Edwin Mak; Donald B Calne; A Jon Stoessl
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
Brain : a journal of neurology 2004;127(Pt 4):888-99.
2004: Alexander Zimprich; Bertram Müller-Myhsok; Matthew J Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew K Wszolek; Thomas Gasser
The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.
American journal of human genetics 2004;74(1):11-9.
2003: Xianwen Chen; Weiguo Liu; Yang Guoyuan; Zhenguo Liu; Stuart Smith; Donald B Calne; Shengdi Chen
Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease.
Parkinsonism & related disorders 2003;10(1):1-7.
2003: Harvey J Clewell; Gregory A Lawrence; Donald B Calne; Kenny S Crump
Determination of an occupational exposure guideline for manganese using the benchmark method.
Risk analysis : an official publication of the Society for Risk Analysis 2003;23(5):1031-46.
2003: Raúl de La Fuente-Fernández; Sarah Furtado; Mark Guttman; Yoshiaki Furukawa; Chong S Lee; Donald B Calne; Thomas J Ruth; A Jon Stoessl
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
Synapse (New York, N.Y.) 2003;49(1):20-8.
2003: Harrup Kaur; Brian D Westerberg; Arthur Mallinson; Donald B Calne
Progressive supranuclear palsy as a cause of balance disorders.
The Journal of otolaryngology 2003;32(2):114-7.
2003: G V McDonnell; J Cabrera-Gomez; Donald B Calne; David K B Li; J Oger
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(2):204-9.
2003: Jason Carr; Raúl de La Fuente-Fernández; Michael Schulzer; Edwin Mak; Susan M Calne; Donald B Calne
Familial and sporadic Parkinson's disease usually display the same clinical features.
Parkinsonism & related disorders 2003;9(4):201-4.
2003: Raúl de La Fuente-Fernández; Andrew S Lim; Vesna Sossi; Michael J Adam; Thomas J Ruth; Donald B Calne; A Jon Stoessl; Chong S Lee
Age and severity of nigrostriatal damage at onset of Parkinson's disease.
Synapse (New York, N.Y.) 2003;47(2):152-8.
2003: Donald B Calne
Parkinson's disease over the last 100 years.
Advances in neurology 2003;91():1-8.
2002: Sarah Furtado; Matthew J Farrer; Yoshio Tsuboi; M L Klimek; Raúl de La Fuente-Fernández; Jennifer Hussey; Paul Lockhart; Donald B Calne; Oksana Suchowersky; A Jon Stoessl; Zbigniew K Wszolek
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
Neurology 2002;59(10):1625-7.
2002: Raúl de La Fuente-Fernández; Anthony G Phillips; Mariangela Zamburlini; Vesna Sossi; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Dopamine release in human ventral striatum and expectation of reward.
Behavioural brain research 2002;136(2):359-63.
2002: Pramod Kumar Pal; Joanne Leung; Katya Hedrich; Ali Samii; Abraham Lieberman; Paul A Nausieda; Donald B Calne; Xandra O Breakefield; Christine Klein; A Jon Stoessl
[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):789-94.
2002: Donald B Calne
Synthetic dopamine agonists.
Expert opinion on pharmacotherapy 2002;3(4):363-4.
2002: Raúl de La Fuente-Fernández; Donald B Calne
Evidence for environmental causation of Parkinson's disease.
Parkinsonism & related disorders 2002;8(4):235-41.
2001: Raúl de La Fuente-Fernández; Andrew S Lim; Vesna Sossi; James E Holden; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(10):1151-9.
2001: Pramod Kumar Pal; Zbigniew K Wszolek; Ryan Uitti; K Markopoulou; Susan M Calne; A Jon Stoessl; Donald B Calne
Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes.
Parkinsonism & related disorders 2001;8(1):51-6.
2001: W J Hwang; Donald B Calne; Joseph K C Tsui; Raúl de La Fuente-Fernández
The long-term response to levodopa in dopa-responsive dystonia.
Parkinsonism & related disorders 2001;8(1):1-5.
2001: Raúl de La Fuente-Fernández; Thomas J Ruth; Vesna Sossi; Michael Schulzer; Donald B Calne; A Jon Stoessl
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
Science (New York, N.Y.) 2001;293(5532):1164-6.
2001: JT Hutton; Leo Verhagen Metman; Thomas N Chase; Jorge L Juncos; William Koller; Rajesh Pahwa; Peter LeWitt; A Samii; J K Tsui; Donald B Calne; C H Waters; V P Calabrese; J P Bennett; R Barrett; J L Morris
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):459-63.
2001: Raúl de La Fuente-Fernández; Donald B Calne
Familial aggregation of Parkinson's disease.
The New England journal of medicine 2001;344(15):1168.
2001: Raúl de La Fuente-Fernández; J Q Lu; Vesna Sossi; Salma Jivan; Michael Schulzer; James E Holden; Chong S Lee; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
Annals of neurology 2001;49(3):298-303.
2000: Pramod Kumar Pal; Ali Samii; A Kishore; Michael Schulzer; Edwin Mak; S Yardley; IM Turnbull; Donald B Calne
Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.
Journal of neurology, neurosurgery, and psychiatry 2000;69(3):337-44.
2000: Raúl de La Fuente-Fernández; A Kishore; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Nigrostriatal dopamine system and motor lateralization.
Behavioural brain research 2000;112(1-2):63-8.
2000: Blaine L Beaman; D Canfield; J Anderson; B Pate; Donald B Calne
Site-specific invasion of the basal ganglia by Nocardia asteroides GUH-2.
Medical microbiology and immunology 2000;188(4):161-8.
2000: Chong S Lee; Ali Samii; Vesna Sossi; Thomas J Ruth; Michael Schulzer; James E Holden; J Wudel; Pramod Kumar Pal; Raul de la Fuente-Fernandez; Donald B Calne; A Jon Stoessl
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Annals of neurology 2000;47(4):493-503.
2000: BJ Snow; FJ Vingerhoets; J William Langston; J W Tetrud; Vesna Sossi; Donald B Calne
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2000;68(3):313-6.
2000: Pramod Kumar Pal; Donald B Calne; Susan M Calne; Joseph K C Tsui
Botulinum toxin A as treatment for drooling saliva in PD.
Neurology 2000;54(1):244-7.
2000: Raúl de La Fuente-Fernández; Pramod Kumar Pal; FJ Vingerhoets; A Kishore; Michael Schulzer; Edwin Mak; Thomas J Ruth; BJ Snow; Donald B Calne; A Jon Stoessl
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):49-57.
1999: Ali Samii; K Markopoulou; Zbigniew K Wszolek; Vesna Sossi; Teresa Dobko; Edwin Mak; Donald B Calne; A Jon Stoessl
PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
Neurology 1999;53(9):2097-102.
1999: Yves Agid; E Ahlskog; A Albanese; Donald B Calne; Thomas N Chase; J De Yebenes; Stewart A Factor; Stanley Fahn; Oscar S Gershanik; Christopher G Goetz; William Koller; M Kurth; Anthony E Lang; Andrew J Lees; Peter LeWitt; D Marsden; Eldad Melamed; Patrick P Michel; Yoshikuni Mizuno; Jose A Obeso; Wolfgang H Oertel; W Olanow; Werner Poewe; Pierre Pollak; Eduardo Tolosa
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Joseph K C Tsui; Donald B Calne; Y Wang; Michael Schulzer; Stephen A Marion
Occupational risk factors in Parkinson's disease.
Canadian journal of public health = Revue canadienne de santé publique 1999;90(5):334-7.
1999: Christopher R Honey; A Jon Stoessl; Joseph K C Tsui; Michael Schulzer; Donald B Calne
Unilateral pallidotomy for reduction of parkinsonian pain.
Journal of neurosurgery 1999;91(2):198-201.
1999: Pramod Kumar Pal; Ali Samii; Donald B Calne
Manganese neurotoxicity: a review of clinical features, imaging and pathology.
Neurotoxicology 1999;20(2-3):227-38.
1999: Ali Samii; IM Turnbull; A Kishore; Michael Schulzer; Edwin Mak; S Yardley; Donald B Calne
Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
Brain : a journal of neurology 1999;122 ( Pt 3)():417-25.
1999: GL Chan; James E Holden; A Jon Stoessl; Ali Samii; Doris J Doudet; Teresa Dobko; KS Morrison; M Adam; Michael Schulzer; Donald B Calne; Thomas J Ruth
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):283-9.
1999: Donald B Calne
Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1999;56():185-92.
1998: Daniel P Perl; C Warren Olanow; Donald B Calne
Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?
Annals of neurology 1998;44(3 Suppl 1):S19-31.
1998: Y Wang; GL Chan; James E Holden; Teresa Dobko; Edwin Mak; Michael Schulzer; J M Huser; BJ Snow; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Age-dependent decline of dopamine D1 receptors in human brain: a PET study.
Synapse (New York, N.Y.) 1998;30(1):56-61.
1998: Raul de la Fuente-Fernandez; Michael Schulzer; Edwin Mak; A Kishore; Donald B Calne
The role of the Lewy body in idiopathic Parkinsonism.
Parkinsonism & related disorders 1998;4(2):73-7.
1998: MD Muenter; L S Forno; Oleh Hornykiewicz; Stephen J Kish; Demetrius M Maraganore; Richard Caselli; H Okazaki; F M Howard; BJ Snow; Donald B Calne
Hereditary form of parkinsonism--dementia.
Annals of neurology 1998;43(6):768-81.
1998: GL Chan; James E Holden; A Jon Stoessl; Doris J Doudet; Y Wang; Teresa Dobko; KS Morrison; J M Huser; C English; B Legg; Michael Schulzer; Donald B Calne; Thomas J Ruth
Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):792-7.
1998: A Kishore; T G Nygaard; Raul de la Fuente-Fernandez; A B Naini; Michael Schulzer; Edwin Mak; Thomas J Ruth; Donald B Calne; BJ Snow; A Jon Stoessl
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Neurology 1998;50(4):1028-32.
1998: Chin-Chang Huang; Nai-Shin Chu; Chin-Song Lu; Rou-Shayn Chen; Donald B Calne
Long-term progression in chronic manganism: ten years of follow-up.
Neurology 1998;50(3):698-700.
1998: Thomas Gasser; Bertram Müller-Myhsok; Zbigniew K Wszolek; R Oehlmann; Donald B Calne; Vincenzo Bonifati; Benjamin Bereznai; Edito Fabrizio; Peter Vieregge; R D Horstmann
A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
Nature genetics 1998;18(3):262-5.
1997: Zbigniew K Wszolek; Peter Vieregge; Ryan Uitti; Thomas Gasser; O Yasuhara; Patrick L McGeer; K Berry; Donald B Calne; F J Vingerhoets; Christine Klein; Ronald F Pfeiffer
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.
Parkinsonism & related disorders 1997;3(3):125-39.
1997: H Shinotoh; B Thiessen; BJ Snow; S Hashimoto; Patrick M MacLeod; I Silveira; Guy Rouleau; Michael Schulzer; Donald B Calne
Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
Neurology 1997;49(4):1133-6.
1997: Doris J Doudet; GL Chan; James E Holden; B D Pate; KS Morrison; Donald B Calne; Thomas J Ruth
Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
European journal of pharmacology 1997;334(1):31-8.
1997: Chin-Chang Huang; Nai-Shin Chu; Chin-Song Lu; Donald B Calne
Cock gait in manganese intoxication.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):807-8.
1997: A Kishore; IM Turnbull; BJ Snow; Raul de la Fuente-Fernandez; Michael Schulzer; Edwin Mak; S Yardley; Donald B Calne
Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations.
Brain : a journal of neurology 1997;120 ( Pt 5)():729-37.
1997: Ryan Uitti; H Shinotoh; M Hayward; Michael Schulzer; Edwin Mak; Donald B Calne
"Familial Parkinson's disease"--a case-control study of families.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1997;24(2):127-32.
1997: H Shinotoh; F J Vingerhoets; C S Lee; Ryan Uitti; Michael Schulzer; Donald B Calne; Joseph K C Tsui
Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
Neurology 1997;48(5):1282-5.
1997: H Shinotoh; BJ Snow; N S Chu; C C Huang; C S Lu; C Lee; H Takahashi; Donald B Calne
Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Neurology 1997;48(4):1053-6.
1997: Y Wang; IM Turnbull; Susan M Calne; A Jon Stoessl; Donald B Calne
Pallidotomy for tardive dyskinesia.
Lancet 1997;349(9054):777-8.
1997: Donald B Calne; Raúl de La Fuente-Fernández; A Kishore
Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
Journal of neural transmission. Supplementum 1997;50():47-52.
1997: FJ Vingerhoets; Michael Schulzer; Donald B Calne; BJ Snow
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Annals of neurology 1997;41(1):58-64.
1996: A Kishore; Zbigniew K Wszolek; BJ Snow; Raul de la Fuente-Fernandez; Fré Arwert; M Wijker; Michael Schulzer; Donald B Calne; FJ Vingerhoets
Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.
Neurology 1996;47(6):1588-90.
1996: I Litvan; Yves Agid; Donald B Calne; G Campbell; Bruno Dubois; RC Duvoisin; Christopher G Goetz; Lawrence I Golbe; Jordan Grafman; John H Growdon; Mark Hallett; Joseph Jankovic; Niall Quinn; E Tolosa; David S Zee
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
1996: C Warren Olanow; Paul F Good; H Shinotoh; K A Hewitt; FJ Vingerhoets; BJ Snow; M Flint Beal; Donald B Calne; Daniel P Perl
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
Neurology 1996;46(2):492-8.
1996: Nai-Shin Chu; Chin-Chang Huang; Donald B Calne
Sympathetic skin response and RR interval variation in manganism and a comparison with Parkinson's disease.
Parkinsonism & related disorders 1996;2(1):23-8.
1996: Thomas Gasser; Zbigniew K Wszolek; A Supala; J Trofatter; Laurie J Ozelius; Ryan Uitti; Ronald F Pfeiffer; James Gusella; Donald B Calne; Xandra O Breakefield
Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
Advances in neurology 1996;69():87-95.
1995: Donald B Calne
Selegiline in Parkinson's disease.
BMJ (Clinical research ed.) 1995;311(7020):1583-4.
1995: S K Lin; C S Lu; F Vingerhoets; B J Snow; Y Y Wai; N S Chu; Donald B Calne
Isolated involvement of substantia nigra in acute transient parkinsonism: MRI and PET observations.
Parkinsonism & related disorders 1995;1(2):67-72.
1995: J Duarte; Luis Erik Clavería; J de Pedro-Cuesta; A P Sempere; F Coria; Donald B Calne
Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivity.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):643-9.
1995: H Shinotoh; Donald B Calne
The use of PET in Parkinson's disease.
Brain and cognition 1995;28(3):297-310.
1995: Ryan Uitti; K Berry; O Yasuhara; A Eisen; H Feldman; Patrick L McGeer; Donald B Calne
Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease.
Parkinsonism & related disorders 1995;1(1):21-34.
1995: Donald B Calne
Editorial.
Parkinsonism & related disorders 1995;1(1):1.
1995: H Shinotoh; BJ Snow; K A Hewitt; B D Pate; Doris J Doudet; R Nugent; Daniel P Perl; W Olanow; Donald B Calne
MRI and PET studies of manganese-intoxicated monkeys.
Neurology 1995;45(6):1199-204.
1995: Zbigniew K Wszolek; B Pfeiffer; J R Fulgham; Joseph E Parisi; B M Thompson; Ryan Uitti; Donald B Calne; Ronald F Pfeiffer
Western Nebraska family (family D) with autosomal dominant parkinsonism.
Neurology 1995;45(3 Pt 1):502-5.
1995: C S Lee; Michael Schulzer; Edwin Mak; John P Hammerstad; S Calne; Donald B Calne
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis.
Neurology 1995;45(3 Pt 1):435-9.
1995: Donald B Calne
Diagnosis and treatment of Parkinson's disease.
Hospital practice (Office ed.) 1995;30(1):83-6, 89.
1994: FJ Vingerhoets; BJ Snow; J W Tetrud; J William Langston; Michael Schulzer; Donald B Calne
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Annals of neurology 1994;36(5):765-70.
1994: FJ Vingerhoets; BJ Snow; C S Lee; Michael Schulzer; Edwin Mak; Donald B Calne
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.
Annals of neurology 1994;36(5):759-64.
1994: H Shinotoh; Donald B Calne; B Snow; M Hayward; B Kremer; J Theilmann; Michael R Hayden
Normal CAG repeat length in the Huntington's disease gene in senile chorea.
Neurology 1994;44(11):2183-4.
1994: M Cordes; BJ Snow; S Cooper; M Schulzer; B D Pate; Thomas J Ruth; Donald B Calne
Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Annals of neurology 1994;36(4):667-70.
1994: C S Lu; Chin-Chang Huang; Nai-Shin Chu; Donald B Calne
Levodopa failure in chronic manganism.
Neurology 1994;44(9):1600-2.
1994: Donald B Calne; Nai-Shin Chu; Chin-Chang Huang; C S Lu; W Olanow
Manganism and idiopathic parkinsonism: similarities and differences.
Neurology 1994;44(9):1583-6.
1994: Thomas Gasser; Zbigniew K Wszolek; J Trofatter; Laurie J Ozelius; Ryan Uitti; C S Lee; James Gusella; Ronald F Pfeiffer; Donald B Calne; Xandra O Breakefield
Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.
Annals of neurology 1994;36(3):387-96.
1994: Donald B Calne
Initiating treatment for idiopathic parkinsonism.
Neurology 1994;44(7 Suppl 6):S19-22.
1994: Michael Schulzer; C S Lee; Edwin Mak; FJ Vingerhoets; Donald B Calne
A mathematical model of pathogenesis in idiopathic parkinsonism.
Brain : a journal of neurology 1994;117 ( Pt 3)():509-16.
1994: C S Lee; Michael Schulzer; Edwin Mak; BJ Snow; J K Tsui; S Calne; John P Hammerstad; Donald B Calne
Clinical observations on the rate of progression of idiopathic parkinsonism.
Brain : a journal of neurology 1994;117 ( Pt 3)():501-7.
1994: Ryan Uitti; BJ Snow; H Shinotoh; FJ Vingerhoets; M Hayward; S Hashimoto; J Richmond; Sanford Markey; C J Markey; Donald B Calne
Parkinsonism induced by solvent abuse.
Annals of neurology 1994;35(5):616-9.
1994: Donald B Calne
Dopa-responsive dystonia.
Annals of neurology 1994;35(4):381-2.
1994: H Takahashi; R A Levine; matthew galloway; BJ Snow; Donald B Calne; TG Nygaard
Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia.
Annals of neurology 1994;35(3):354-6.
1994: Donald B Calne; RC Duvoisin; William Koller
Individualizing therapy in patients with disabling Parkinson's disease symptoms.
Neurology 1994;44(3 Suppl 1):S8-11.
1994: Donald B Calne
Early idiopathic parkinsonism: initiation and optimization of treatment.
Clinical neuropharmacology 1994;17 Suppl 2():S14-8.
1994: Donald B Calne
Is idiopathic parkinsonism the consequence of an event or a process?
Neurology 1994;44(1):5-10.
1994: FJ Vingerhoets; BJ Snow; Michael Schulzer; S Morrison; Thomas J Ruth; James E Holden; S Cooper; Donald B Calne
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(1):18-24.
1994: Clyde Hertzman; M Wiens; B Snow; Shona Kelly; Donald B Calne
A case-control study of Parkinson's disease in a horticultural region of British Columbia.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):69-75.
1994: FJ Vingerhoets; Ryan Uitti; Donald B Calne
Deprenyl and the issue of neuroprotection.
European neurology 1994;34(1):1-3.
1994: John P Hammerstad; K Elliott; Edwin Mak; Michael Schulzer; S Calne; Donald B Calne
Tendon jerks in Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(1-2):123-30.
1993: BJ Snow; TG Nygaard; H Takahashi; Donald B Calne
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
Annals of neurology 1993;34(5):733-8.
1993: Michael Schulzer; Donald B Calne; B Snow; Edwin Mak
A scoring error in the Mini-Mental State test.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1993;38(9):603-5.
1993: H Takahashi; BJ Snow; M H Bhatt; R Peppard; Andrew Eisen; Donald B Calne
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Lancet 1993;342(8878):1016-8.
1993: John P Hammerstad; B D Pate; K A Hewitt; GL Chan; Thomas J Ruth; Donald B Calne
The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brain.
Annals of neurology 1993;34(4):603-8.
1993: Donald B Calne
Treatment of Parkinson's disease.
The New England journal of medicine 1993;329(14):1021-7.
1993: Guila Glosser; N Wolfe; Martin L Albert; L Lavine; John C Steele; Donald B Calne; B S Schoenberg
Cross-cultural cognitive examination: validation of a dementia screening instrument for neuroepidemiological research.
Journal of the American Geriatrics Society 1993;41(9):931-9.
1993: B D Pate; T Kawamata; Tatsuo Yamada; Edith G McGeer; K A Hewitt; BJ Snow; Thomas J Ruth; Donald B Calne
Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
Annals of neurology 1993;34(3):331-8.
1993: BJ Snow; I Tooyama; Edith G McGeer; Tatsuo Yamada; Donald B Calne; H Takahashi; H Kimura
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Annals of neurology 1993;34(3):324-30.
1993: CH Waters; H Takahashi; Kirk Wilhelmsen; R Shubin; BJ Snow; TG Nygaard; C B Moskowitz; Stanley Fahn; Donald B Calne
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
Neurology 1993;43(8):1555-8.
1993: Chin-Chang Huang; C S Lu; Nai-Shin Chu; F Hochberg; D Lilienfeld; W Olanow; Donald B Calne
Progression after chronic manganese exposure.
Neurology 1993;43(8):1479-83.
1993: Zbigniew K Wszolek; M Cordes; Donald B Calne; M D Münter; I Cordes; R F Pfeifer
[Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance].
Der Nervenarzt 1993;64(5):331-5.
1993: J K Tsui; M Bhatt; S Calne; Donald B Calne
Botulinum toxin in the treatment of writer's cramp: a double-blind study.
Neurology 1993;43(1):183-5.
1993: A Okada; K Nakamura; BJ Snow; M H Bhatt; M Nomoto; M Osame; Donald B Calne
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
Advances in neurology 1993;60():591-4.
1993: H Takahashi; BJ Snow; TG Nygaard; Donald B Calne
Clinical heterogeneity of dopa-responsive dystonia: PET observations.
Advances in neurology 1993;60():586-90.
1993: Donald B Calne; BJ Snow
PET imaging in Parkinsonism.
Advances in neurology 1993;60():484-7.
1993: M Cordes; BJ Snow; S Morrison; Vesna Sossi; Thomas J Ruth; Donald B Calne
Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
Neuroradiology 1993;35(6):404-9.
1993: Ryan Uitti; Donald B Calne
Pathogenesis of idiopathic parkinsonism.
European neurology 1993;33 Suppl 1():6-23.
1993: Tatsuo Yamada; Donald B Calne; Haruhiko Akiyama; Edith G McGeer; Patrick L McGeer
Further observations on Tau-positive glia in the brains with progressive supranuclear palsy.
Acta neuropathologica 1993;85(3):308-15.
1992: Donald B Calne
The free radical hypothesis in idiopathic parkinsonism: evidence against it.
Annals of neurology 1992;32(6):799-803.
1992: Michael Schulzer; Edwin Mak; Donald B Calne
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic.
Annals of neurology 1992;32(6):795-8.
1992: R F Peppard; W R Wayne Martin; G D Carr; E Grochowski; Michael Schulzer; M Guttman; Patrick L McGeer; A G Phillips; J K Tsui; Donald B Calne
Cerebral glucose metabolism in Parkinson's disease with and without dementia.
Archives of neurology 1992;49(12):1262-8.
1992: TG Nygaard; H Takahashi; Gary A Heiman; BJ Snow; Stanley Fahn; Donald B Calne
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Annals of neurology 1992;32(5):603-8.
1992: Zbigniew K Wszolek; Ronald F Pfeiffer; M H Bhatt; RL Schelper; M Cordes; BJ Snow; R L Rodnitzky; Erik C Wolters; Fré Arwert; Donald B Calne
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration.
Annals of neurology 1992;32(3):312-20.
1992: Donald B Calne; R Calne
Citation of original research.
Lancet 1992;340(8813):244.
1992: Donald B Calne; F H Hochberg; B J Snow; T Nygaard
Theories of neurodegeneration.
Annals of the New York Academy of Sciences 1992;648():1-5.
1992: Bala V Manyam; M H Bhatt; W D Moore; A B Devleschoward; D R Anderson; Donald B Calne
Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies.
Annals of neurology 1992;31(4):379-84.
1992: C Warren Olanow; Donald B Calne
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?
Neurology 1992;42(4 Suppl 4):13-26; discussion 41-8.
1992: M Cordes; BJ Snow; H Takahashi; P Schofield; S Cooper; Vesna Sossi; S Morrison; Donald B Calne
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
Nuklearmedizin. Nuclear medicine 1992;31(2):43-7.
1992: Donald B Calne
The nature of Parkinson's disease.
Neurochemistry international 1992;20 Suppl():1S-3S.
1992: A Eisen; Donald B Calne
Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1 Suppl):117-23.
1992: Donald B Calne; BJ Snow; C Lee
Criteria for diagnosing Parkinson's disease.
Annals of neurology 1992;32 Suppl():S125-7.
1991: M H Bhatt; S P Keenan; John A Fleetham; Donald B Calne
Pleuropulmonary disease associated with dopamine agonist therapy.
Annals of neurology 1991;30(4):613-6.
1991: Donald B Calne; Andrew Eisen; Graydon S Meneilly
Normal aging of the nervous system.
Annals of neurology 1991;30(2):206-7.
1991: B D Pate; BJ Snow; K A Hewitt; KS Morrison; Thomas J Ruth; Donald B Calne
The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1246-51.
1991: M H Bhatt; BJ Snow; W R Wayne Martin; B D Pate; Thomas J Ruth; Donald B Calne
Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow.
Annals of neurology 1991;29(6):673-7.
1991: Andrew Eisen; S Siejka; Michael Schulzer; Donald B Calne
Age-dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1991;81(3):209-15.
1991: Donald B Calne; Michael Zigmond
Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism.
Archives of neurology 1991;48(4):361-3.
1991: M H Bhatt; BJ Snow; W R Wayne Martin; R Peppard; Donald B Calne
Positron emission tomography in progressive supranuclear palsy.
Archives of neurology 1991;48(4):389-91.
1991: Ali H Rajput; Donald B Calne; Anthony E Lang
National conference on Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(1):87-92.
1991: BJ Snow; M Bhatt; W R Wayne Martin; D Li; Donald B Calne
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1991;54(1):12-7.
1991: L Lavine; John C Steele; N Wolfe; Donald B Calne; P C O'Brien; D B Williams; L T Kurland; B S Schoenberg
Amyotrophic lateral sclerosis/parkinsonism-dementia complex in southern Guam: is it disappearing?
Advances in neurology 1991;56():271-85.
1991: Donald B Calne
Neurotoxins and degeneration in the central nervous system.
Neurotoxicology 1991;12(3):335-9.
1990: R F Peppard; W R Wayne Martin; C M Clark; G D Carr; Patrick L McGeer; Donald B Calne
Cortical glucose metabolism in Parkinson's and Alzheimer's disease.
Journal of neuroscience research 1990;27(4):561-8.
1990: BJ Snow; J K Tsui; M H Bhatt; M Varelas; S A Hashimoto; Donald B Calne
Treatment of spasticity with botulinum toxin: a double-blind study.
Annals of neurology 1990;28(4):512-5.
1990: BJ Snow; R F Peppard; M Guttman; J Okada; W R Wayne Martin; J Steele; Andrew Eisen; G Carr; B Schoenberg; Donald B Calne
Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam.
Archives of neurology 1990;47(8):870-4.
1990: R F Peppard; C S Lu; Nai-Shin Chu; Phillip A Teal; W R Wayne Martin; Donald B Calne
Parkinsonism with neuroacanthocytosis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(3):298-301.
1990: M H Bhatt; BJ Snow; W R Wayne Martin; S Cooper; Donald B Calne
Positron emission tomography in Shy-Drager syndrome.
Annals of neurology 1990;28(1):101-3.
1990: J K Tsui; R F Peppard; K C Petruk; G Allen; R S Burns; Donald B Calne
Decreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants.
Neurology 1990;40(5):845-6.
1990: Erik C Wolters; T A Hurwitz; Edwin Mak; Phillip A Teal; F R Peppard; Ronald Remick; S Calne; Donald B Calne
Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis.
Neurology 1990;40(5):832-4.
1990: M Guttman; HC Fibiger; A Jakubovic; Donald B Calne
Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.
Journal of neurochemistry 1990;54(4):1329-34.
1990: Edith G McGeer; R P Peppard; Patrick L McGeer; Holly A Tuokko; D Crockett; R Parks; Haruhiko Akiyama; Donald B Calne; B L Beattie; R Harrop
18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(1):1-11.
1990: Clyde Hertzman; M Wiens; D Bowering; B Snow; Donald B Calne
Parkinson's disease: a case-control study of occupational and environmental risk factors.
American journal of industrial medicine 1990;17(3):349-55.
1990: M Bhatt; Erik C Wolters; J Tsui; BJ Snow; Donald B Calne
A case of rabies in North America.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):40-3.
1990: M Bhatt; B Snow; M Varelas; Donald B Calne
Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):339-40.
1990: Donald B Calne; Andrew Eisen
Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
Advances in neurology 1990;53():355-60.
1990: Kenneth C Petruk; A F Wilson; D R Schindel; N J Witt; D R McLean; P A McFarland; R G Johnston; M S McPhee; W R Wayne Martin; Donald B Calne
Treatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgery.
Progress in brain research 1990;82():671-6.
1989: T A Cox; J V McDarby; L Lavine; John C Steele; Donald B Calne
A retinopathy on Guam with high prevalence in Lytico-Bodig.
Ophthalmology 1989;96(12):1731-5.
1989: V W Yong; M Guttman; Seung Kim; Donald B Calne; I Turnbull; K Watabe; R W Tomlinson
Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms.
Journal of the neurological sciences 1989;94(1-3):51-67.
1989: Donald B Calne; Andrew Eisen
The relationship between Alzheimer's disease, Parkinson's disease and motor neuron disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(4 Suppl):547-50.
1989: Erik C Wolters; C C Huang; C Clark; R F Peppard; J Okada; Nai-Shin Chu; M J Adam; Thomas J Ruth; D Li; Donald B Calne
Positron emission tomography in manganese intoxication.
Annals of neurology 1989;26(5):647-51.
1989: Chin-Chang Huang; Nai-Shin Chu; C S Lu; J D Wang; J L Tsai; J L Tzeng; Erik C Wolters; Donald B Calne
Chronic manganese intoxication.
Archives of neurology 1989;46(10):1104-6.
1989: W R Wayne Martin; M R Palmer; C S Patlak; Donald B Calne
Nigrostriatal function in humans studied with positron emission tomography.
Annals of neurology 1989;26(4):535-42.
1989: B Snow; M Wiens; Clyde Hertzman; Donald B Calne
A community survey of Parkinson's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1989;141(5):418-22.
1989: M Guttman; R S Burns; W R Wayne Martin; R F Peppard; M J Adam; Thomas J Ruth; G Allen; R A Parker; Noel Tulipan; Donald B Calne
PET studies of parkinsonian patients treated with autologous adrenal implants.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(3):305-9.
1989: J K Tsui; Erik C Wolters; R F Peppard; Donald B Calne
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease.
Neurology 1989;39(6):856-8.
1989: Donald B Calne
Is "Parkinson's disease" one disease?
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():18-21.
1989: J Okada; R Peppard; Donald B Calne
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Nihon Igaku Hōshasen Gakkai zasshi. Nippon acta radiologica 1989;49(5):643-56.
1989: H Teräväinen; J K Tsui; Edwin Mak; Donald B Calne
Optimal indices for testing parkinsonian rigidity.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(2):180-3.
1989: Erik C Wolters; T A Hurwitz; R F Peppard; Donald B Calne
Clozapine: an antipsychotic agent in Parkinson's disease?
Clinical neuropharmacology 1989;12(2):83-90.
1989: J K Tsui; S Ross; K Poulin; J Douglas; D Postnikoff; S Calne; William R Woodward; Donald B Calne
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
Neurology 1989;39(4):549-52.
1989: Donald B Calne; A Dubini; G Stern
Did Leonardo describe Parkinson's disease?
The New England journal of medicine 1989;320(9):594.
1989: Erik C Wolters; Donald B Calne
Parkinson's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1989;140(5):507-14.
1989: Donald B Calne
Current concepts on the etiology of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S11-4.
1988: Erik C Wolters; J C Kebabian; M Guttman; Edwin Mak; B D Pate; Donald B Calne
A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
Neuroscience letters 1988;95(1-3):257-61.
1988: F E Lepore; John C Steele; T A Cox; G Tillson; Donald B Calne; RC Duvoisin; L Lavine; J V McDarby
Supranuclear disturbances of ocular motility in Lytico-Bodig.
Neurology 1988;38(12):1849-53.
1988: Donald B Calne; Patrick L McGeer
Tissue transplantation for Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(4):364-5.
1988: Donald B Calne
Parkinson's disease over the last 20 years: a personal view.
Functional neurology 1988;3(4):395-406.
1988: Donald B Calne; Andrew J Lees
Late progression of post-encephalitic Parkinson's syndrome.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(2):135-8.
1988: T A Hurwitz; Donald B Calne; K Waterman
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(1):32-4.
1988: Donald B Calne; J S Calne
Normality and disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(1):3-4.
1988: J K Tsui; Andrew Eisen; Donald B Calne
Botulinum toxin in spasmodic torticollis.
Advances in neurology 1988;50():593-7.
1988: Oksana Suchowersky; Donald B Calne
Non-dystonic causes of torticollis.
Advances in neurology 1988;50():501-8.
1988: J K Tsui; Donald B Calne
Botulinum toxin in cervical dystonia.
Advances in neurology 1988;49():473-8.
1988: Donald B Calne
Options for the etiology of Parkinson's disease: the association with dementia.
The Mount Sinai journal of medicine, New York 1988;55(1):58-61.
1988: M Guttman; V W Yong; Seung Kim; Donald B Calne; W R Wayne Martin; M J Adam; Thomas J Ruth
Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
Synapse (New York, N.Y.) 1988;2(5):469-73.
1988: W R Wayne Martin; A Jon Stoessl; M Palmer; M J Adam; Thomas J Ruth; J R Grierson; B D Pate; Donald B Calne
PET scanning in dystonia.
Advances in neurology 1988;50():223-9.
1988: H Shale; Stanley Fahn; Donald B Calne
Case 1, 1988. Head tilt in a young girl associated with neck pain and limitation of neck movement.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):347-51.
1988: Donald B Calne; Anthony E Lang
Secondary dystonia.
Advances in neurology 1988;50():9-33.
1988: H Teräväinen; S Calne; K Burton; J Beckman; Donald B Calne
Efficacy of dopamine agonists in dystonia.
Advances in neurology 1988;50():571-8.
1987: J K Tsui; R D Fross; S Calne; Donald B Calne
Local treatment of spasmodic torticollis with botulinum toxin.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):533-5.
1987: Donald B Calne; R F Peppard
Aging of the nigrostriatal pathway in humans.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):424-7.
1987: S Calne; B Schoenberg; W Martin; Ryan Uitti; Peter S Spencer; Donald B Calne
Familial Parkinson's disease: possible role of environmental factors.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3):303-5.
1987: R D Fross; W R Wayne Martin; D Li; A Jon Stoessl; M J Adam; Thomas J Ruth; B D Pate; K Burton; Donald B Calne
Lesions of the putamen: their relevance to dystonia.
Neurology 1987;37(7):1125-9.
1987: H Kamo; Patrick L McGeer; R Harrop; Edith G McGeer; Donald B Calne; W R Wayne Martin; B D Pate
Positron emission tomography and histopathology in Pick's disease.
Neurology 1987;37(3):439-45.
1987: Donald B Calne; A Jon Stoessl
Transmitter receptor alterations in Parkinson's disease.
Advances in neurology 1987;45():45-9.
1986: Donald B Calne; A Eisen; Edith G McGeer; Peter S Spencer
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
Lancet 1986;2(8515):1067-70.
1986: Heikki Teräväinen; L Forgach; Marja Hietanen; M Schulzer; B Schoenberg; Donald B Calne
The age of onset of Parkinson's disease: etiological implications.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4):317-9.
1986: Heikki Teräväinen; Marja Hietanen; J Stoessl; Donald B Calne
Dementia in movement disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):546-58.
1986: J K Tsui; Andrew Eisen; A Jon Stoessl; S Calne; Donald B Calne
Double-blind study of botulinum toxin in spasmodic torticollis.
Lancet 1986;2(8501):245-7.
1986: Patrick L McGeer; H Kamo; R Harrop; D K Li; Holly A Tuokko; Edith G McGeer; M J Adam; W Ammann; B L Beattie; Donald B Calne
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1986;134(6):597-607.
1986: Nadir Bharucha; L Stokes; B S Schoenberg; C Ward; S Ince; John G Nutt; R Eldridge; Donald B Calne; N Mantel; RC Duvoisin
A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors.
Neurology 1986;36(2):284-8.
1986: E Lau; K Waterman; R Glover; M Schulzer; Donald B Calne
Effect of antacid on levodopa therapy.
Clinical neuropharmacology 1986;9(5):477-9.
1986: C B Bozek; O Suchowersky; S Purves; S Calne; Donald B Calne
Sinemet in Parkinson's disease: efficacy with and without food.
Clinical neuropharmacology 1986;9(2):196-9.
1986: Donald B Calne; A Jon Stoessl
Early parkinsonism.
Clinical neuropharmacology 1986;9 Suppl 2():S3-8.
1986: Donald B Calne; UK Rinne
Controversies in the management of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):159-62.
1985: A Jon Stoessl; Edwin Mak; Donald B Calne
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.
Lancet 1985;2(8468):1330-1.
1985: J K Tsui; Andrew Eisen; Edwin Mak; J Carruthers; A Scott; Donald B Calne
A pilot study on the use of botulinum toxin in spasmodic torticollis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1985;12(4):314-6.
1985: Donald B Calne; J William Langston; W R Wayne Martin; A Jon Stoessl; Thomas J Ruth; M J Adam; B D Pate; M Schulzer
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature 1985;317(6034):246-8.
1985: K Burton; T A Larsen; R G Robinson; P J Bratty; W R Martin; M Schulzer; Donald B Calne
Parkinson's disease: a comparison of mesulergine and bromocriptine.
Neurology 1985;35(8):1205-8.
1985: R P Newman; Peter LeWitt; M Jaffe; Donald B Calne; T A Larsen
Motor function in the normal aging population: treatment with levodopa.
Neurology 1985;35(4):571-3.
1985: T A Larsen; H G Dunn; J E Jan; Donald B Calne
Dystonia and calcification of the basal ganglia.
Neurology 1985;35(4):533-7.
1985: A Eisen; M Hoirch; M Fink; T Goya; Donald B Calne
Noninvasive measurement of central sensory and motor conduction.
Neurology 1985;35(4):503-9.
1985: I M Turnbull; Patrick L McGeer; L Beattie; Donald B Calne; B Pate
Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer's type. A preliminary report.
Applied neurophysiology 1985;48(1-6):216-21.
1985: R P Newman; Peter LeWitt; Clifford W Shults; G Bruno; N L Foster; Thomas N Chase; Donald B Calne
Dystonia: treatment with bromocriptine.
Clinical neuropharmacology 1985;8(4):328-33.
1984: A Eisen; M Hoirch; J White; Donald B Calne
Sensory group Ia proximal conduction velocity.
Muscle & nerve 1984;7(8):636-41.
1984: K Burton; Donald B Calne
Pharmacology of Parkinson's disease.
Neurologic clinics 1984;2(3):461-72.
1984: K Burton; K Farrell; D Li; Donald B Calne
Lesions of the putamen and dystonia: CT and magnetic resonance imaging.
Neurology 1984;34(7):962-5.
1984: T A Larsen; R Newman; Peter LeWitt; Donald B Calne
Severity of Parkinson's disease and the dosage of bromocriptine.
Neurology 1984;34(6):795-7.
1984: R P Newman; H Weingartner; S A Smallberg; Donald B Calne
Effortful and automatic memory: effects of dopamine.
Neurology 1984;34(6):805-7.
1984: A Eisen; K Burton; A Larsen; M Hoirch; Donald B Calne
A new indirect method for measuring spinal conduction velocity in man.
Electroencephalography and clinical neurophysiology 1984;59(3):204-13.
1984: R P Newman; Donald B Calne
Diagnosis and management of Parkinson's disease.
Geriatrics 1984;39(5):87-91, 94, 96.
1984: R S Burns; G Gopinathan; M Hümpel; R Dorow; Donald B Calne
Disposition of oral lisuride in Parkinson's disease.
Clinical pharmacology and therapeutics 1984;35(4):548-56.
1984: Donald B Calne
Progress in Parkinson's disease.
The New England journal of medicine 1984;310(8):523-4.
1984: W R Wayne Martin; J H Beckman; Donald B Calne; M J Adam; R Harrop; J G Rogers; Thomas J Ruth; C I Sayre; B D Pate
Cerebral glucose metabolism in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):169-73.
1984: C D Ward; I K Trombley; Donald B Calne; I J Kopin
L-dopa decarboxylation in chronically treated patients.
Neurology 1984;34(2):198-201.
1984: Donald B Calne; K Burton; J Beckman; W R Martin
Dopamine agonists in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):221-4.
1984: T A Larsen; S Calne; Donald B Calne
Assessment of Parkinson's disease.
Clinical neuropharmacology 1984;7(2):165-9.
1984: Donald B Calne; RC Duvoisin; Edith G McGeer
Speculations on the etiology of Parkinson's disease.
Advances in neurology 1984;40():353-60.
1984: C D Ward; RC Duvoisin; S E Ince; John G Nutt; R Eldridge; Donald B Calne; J Dambrosia
Parkinson's disease in twins.
Advances in neurology 1984;40():341-4.
1984: Peter LeWitt; L P Miller; R P Newman; R S Burns; Thomas R Insel; Robert A Levine; W Lovenberg; Donald B Calne
Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.
Advances in neurology 1984;40():459-62.
1984: K Burton; Donald B Calne
Dopamine agonists and Parkinson's disease.
Clinical neurology and neurosurgery 1984;86(3):172-7.
1983: Donald B Calne; J William Langston
Aetiology of Parkinson's disease.
Lancet 1983;2(8365-66):1457-9.
1983: Peter LeWitt; R P Newman; Harry S Greenberg; L L Rocher; Donald B Calne; J R Ehrenkranz
Episodic hyperhidrosis, hypothermia, and agenesis of corpus callosum.
Neurology 1983;33(9):1122-9.
1983: Peter LeWitt; C D Ward; T A Larsen; M I Raphaelson; R P Newman; N Foster; J M Dambrosia; Donald B Calne
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Neurology 1983;33(8):1009-14.
1983: C D Ward; W A Hess; Donald B Calne
Olfactory impairment in Parkinson's disease.
Neurology 1983;33(7):943-6.
1983: C D Ward; RC Duvoisin; S E Ince; John G Nutt; R Eldridge; Donald B Calne
Parkinson's disease in 65 pairs of twins and in a set of quadruplets.
Neurology 1983;33(7):815-24.
1983: Donald B Calne
Current views on Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1983;10(1):11-5.
1983: C D Ward; Jerome N Sanes; J M Dambrosia; Donald B Calne
Methods for evaluating treatment in Parkinson's disease.
Advances in neurology 1983;37():1-7.
1983: Peter LeWitt; R S Burns; Donald B Calne
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
Advances in neurology 1983;37():131-40.
1983: T A Larsen; Donald B Calne
Essential tremor.
Clinical neuropharmacology 1983;6(3):185-206.
1982: C N Karson; Peter LeWitt; Donald B Calne; R J Wyatt
Blink rates in parkinsonism.
Annals of neurology 1982;12(6):580-3.
1982: T A Larsen; Heikki Teräväinen; Donald B Calne
Atenolol vs. propranolol in essential tremor. A controlled, quantitative study.
Acta neurologica Scandinavica 1982;66(5):547-54.
1982: F Karoum; L W Chuang; T Eisler; Donald B Calne; M R Liebowitz; F M Quitkin; D F Klein; R J Wyatt
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Neurology 1982;32(5):503-9.
1982: Donald B Calne
The role of various forms of treatment in the management of Parkinson's disease.
Clinical neuropharmacology 1982;5 Suppl 1():S38-43.
1982: Peter LeWitt; G Gopinathan; C D Ward; Jerome N Sanes; J M Dambrosia; R Durso; Donald B Calne
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
Neurology 1982;32(1):69-72.
1981: T Eisler; M O Thorner; R M MacLeod; D L Kaiser; Donald B Calne
Prolactin secretion in Parkinson disease.
Neurology 1981;31(10):1356-9.
1981: T Eisler; R P Hall; K A Kalavar; Donald B Calne
Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.
Neurology 1981;31(10):1368-70.
1981: G Gopinathan; H Teräväinen; J M Dambrosia; C D Ward; Jerome N Sanes; W K Stuart; E V Evarts; Donald B Calne
Lisuride in parkinsonism.
Neurology 1981;31(4):371-6.
1981: E V Evarts; H Teräväinen; Donald B Calne
Reaction time in Parkinson's disease.
Brain : a journal of neurology 1981;104(Pt 1):167-86.
1981: T Eisler; N Eng; C Plotkin; Donald B Calne
Absorption of levodopa after rectal administration.
Neurology 1981;31(2):215-7.
1981: Ellen K Silbergeld; Donald B Calne
Animal models of parkinsonism.
Pharmacology & therapeutics 1981;12(1):159-66.
1981: RC Duvoisin; R Eldridge; A Williams; John G Nutt; Donald B Calne
Twin study of Parkinson disease.
Neurology 1981;31(1):77-80.
1981: Peter LeWitt; Donald B Calne
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
Journal of neural transmission 1981;51(1-2):175-84.
1981: H Teräväinen; Donald B Calne
Assessment of hypokinesia in Parkinsonism.
Journal of neural transmission 1981;51(1-2):149-59.
1981: T Eisler; H Teräväinen; R Nelson; H Krebs; V Weise; C R Lake; M H Ebert; N Whetzel; D L Murphy; I J Kopin; Donald B Calne
Deprenyl in Parkinson disease.
Neurology 1981;31(1):19-23.
1980: C Ward; J Karsh; Donald B Calne
Cranial herpes zoster: a case report and a hypothesis.
Journal of neurology, neurosurgery, and psychiatry 1980;43(12):1146-7.
1980: A Williams; J Ballenger; Robert A Levine; W Lovenberg; Donald B Calne
Aging and CSF hydroxylase cofactor.
Neurology 1980;30(11):1244-6.
1980: H Teräväinen; Donald B Calne
Studies of parkinsonian movement: 2. Initiation of fast voluntary eye movement during postural disturbance.
Acta neurologica Scandinavica 1980;62(3):149-57.
1980: H Teräväinen; Donald B Calne
Studies of parkinsonian movement: 1. Programming and execution of eye movements.
Acta neurologica Scandinavica 1980;62(3):137-48.
1980: G Gopinathan; Donald B Calne
Incontinence of urine with long-term bromocriptine therapy.
Annals of neurology 1980;8(2):204.
1980: A C Williams; Robert A Levine; Thomas N Chase; W Lovenberg; Donald B Calne
CFS hydroxylase cofactor levels in some neurological diseases.
Journal of neurology, neurosurgery, and psychiatry 1980;43(8):735-8.
1980: H Teräväinen; Donald B Calne
Action tremor in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1980;43(3):257-63.
1980: Donald B Calne; J K Kebabian
Parkinson's disease: unanswered questions.
Journal of neural transmission. Supplementum 1980;(16):1-5.
1980: Donald B Calne; T Eisler; G Gopinathan; A Williams
Progress in the pharmacotherapy of Parkinsonism.
Advances in biochemical psychopharmacology 1980;23():237-43.
1980: P F Teychenne; A J Rosin; C N Plotkin; Donald B Calne
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
British journal of clinical pharmacology 1980;9(1):47-50.
1979: A N Neophytides; P F Teychenne; Ronald F Pfeiffer; Donald B Calne
Sodium valproate in the treatment of cerebellar disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(4):455-7.
1979: Donald B Calne
Neurotransmitters, neuromodulators, and neurohormones.
Neurology 1979;29(11):1517-21.
1979: A Williams; S Houff; Andrew J Lees; Donald B Calne
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1979;42(9):790-2.
1979: John G Nutt; A Williams; C Plotkin; N Eng; M Ziegler; Donald B Calne
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observations.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(3):337-43.
1979: Donald B Calne; T Eisler
The pathogensis and medical treatment of extrapyramidal disease.
The Medical clinics of North America 1979;63(4):715-27.
1979: H Teräväinen; Donald B Calne
Developments in understanding the physiology and pharmacology of parkinsonism.
Acta neurologica Scandinavica 1979;60(1):1-11.
1979: W Lovenberg; Robert A Levine; D S Robinson; M Ebert; A C Williams; Donald B Calne
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease.
Science (New York, N.Y.) 1979;204(4393):624-6.
1979: P F Teychenne; E A Jones; K G Ishak; Donald B Calne
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivative.
Gastroenterology 1979;76(3):575-83.
1979: A Williams; D Hanson; Donald B Calne
Vocal cord paralysis in the Shy-Drager syndrome.
Journal of neurology, neurosurgery, and psychiatry 1979;42(2):151-3.
1979: Donald B Calne; J Kebabian; Ellen K Silbergeld; E Evarts
Advances in the neuropharmacology of Parkinsonism.
Annals of internal medicine 1979;90(2):219-29.
1979: J W Kebabian; Donald B Calne
Multiple receptors for dopamine.
Nature 1979;277(5692):93-6.
1979: Stanley Fahn; A Barbeau; Donald B Calne; RC Duvoisin; C Markham; G Paulson
Symposium I: Therapeutic controversies in movement disorders.
Transactions of the American Neurological Association 1979;104():31-51.
1979: A J Rosin; D Devereux; N Eng; Donald B Calne
Parkinsonism with 'on-off' phenomena. Intravenous treatment with levodopa after major abdominal surgery.
Archives of neurology 1979;36(1):32-4.
1978: John G Nutt; A J Rosin; T Eisler; Donald B Calne; Thomas N Chase
Effect of an opiate antagonist on movement disorders.
Archives of neurology 1978;35(12):810-1.
1978: Donald B Calne; A C Williams; John G Nutt; A Neophytides; T Eisler; P F Teychenne
Ergot derivatives for Parkinsonism.
The Medical journal of Australia 1978;2(3 Suppl):25-6.
1978: Donald B Calne
Parkinsonism. Clinical and neuropharmacologic aspects.
Postgraduate medicine 1978;64(2):82-8.
1978: Donald B Calne
Role of ergot derivatives in the treatment of parkinsonism.
Federation proceedings 1978;37(8):2207-9.
1978: Donald B Calne; C Plotkin; A C Williams; John G Nutt; A Neophytides; P F Teychenne
Long-term treatment of parkinsonism with bromocriptine.
Lancet 1978;1(8067):735-8.
1978: P F Teychenne; Ronald F Pfeiffer; S M Bern; D McInturff; Donald B Calne
Comparison between lergotrile and bromocriptine in parkinsonism.
Annals of neurology 1978;3(4):319-24.
1978: Stanley Fahn; Donald B Calne
Considerations in the management of parkinsonism.
Neurology 1978;28(1):5-7.
1977: P F Teychenne; Ronald F Pfeiffer; S M Bern; Donald B Calne
Experiences with a new ergoline (CF 25-397) in parkinsonism.
Neurology 1977;27(12):1140-3.
1977: Ellen K Silbergeld; H Adler; S Kennedy; Donald B Calne
The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.
The Journal of pharmacy and pharmacology 1977;29(10):632-5.
1977: Donald B Calne
Antiparkinsonian therapy.
Primary care 1977;4(3):533-9.
1977: Donald B Calne
Developments in the pharmacology and therapeutics of parkinsonism.
Annals of neurology 1977;1(2):111-9.
1977: Donald B Calne; P F Teychenne; Ronald F Pfeiffer
Treatment of parkinsonism.
Advances in experimental medicine and biology 1977;90():49-61.
1977: Donald B Calne; P F Teychenne
L-DOPA effect on blood pressure in man.
Progress in brain research 1977;47():331-6.
1977: J W Kebabian; Donald B Calne; P R Kebabian
Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.
Communications in psychopharmacology 1977;1(4):311-8.
1976: Donald B Calne
Developments in the treatment of parkinsonism.
The New England journal of medicine 1976;295(25):1433-4.
1976: P F Teychenne; D M Park; L J Findley; F C Rose; Donald B Calne
Nomifensine in parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1976;39(12):1219-21.
1976: I N Walters; P F Teychenne; L E Claveria; Donald B Calne
Penicillin transport from cerebrospinal fluid.
Neurology 1976;26(11):1008-10.
1976: R Kartzinel; P TEYCHENNE; M M Gillespie; M Perlow; Andrea Carlson Gielen; D A Sadowsky; Donald B Calne
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Lancet 1976;2(7980):272-5.
1976: R Kartzinel; Ira Shoulson; Donald B Calne
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Neurology 1976;26(8):741-3.
1976: R Kartzinel; R D Hunt; Donald B Calne
Bromocriptine in Huntington chorea.
Archives of neurology 1976;33(7):517-8.
1976: P F Teychenne; I Walters; L E Claveria; Donald B Calne; J Price; B B Macgillivary; D Gompertz
The encephalopathic action of five-carbon-atom fatty acids in the rabbit.
Clinical science and molecular medicine 1976;50(6):463-72.
1976: R Kartznel; Donald B Calne
Studies with bromocriptine. Part 1. "On-off" phenomena.
Neurology 1976;26(6 PT 1):508-10.
1976: R Kartzinel; Ira Shoulson; Donald B Calne
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Neurology 1976;26(6 PT 1):511-3.
1976: Donald B Calne; J Fermaglich
Gout induced by L-dopa and decarboxylase inhibitors.
Postgraduate medical journal 1976;52(606):232-3.
1976: D J Amico; Donald B Calne; H L Klawans
Altered hypothermic responsivness to (+)-amphetamine.
The Journal of pharmacy and pharmacology 1976;28(2):154-6.
1976: P F Teychenne; R Kartzinel; M Perlow; Ronald F Pfeiffer; Donald B Calne
Clinical studies with bromocriptine in idiopathic parkinsonism.
Transactions of the American Neurological Association 1976;101():302-4.
1976: Donald B Calne; Ira Shoulson; R Kartzinel
An ergot derivative in the treatment of Parkinson's disease.
Postgraduate medical journal 1976;52suppl 1():81-5.
1976: R Kartzinel; M D Perlow; A C Carter; Thomas N Chase; Donald B Calne; Ira Shoulson
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Transactions of the American Neurological Association 1976;101():53-6.
1975: P F Teychenne; P N Leigh; J L Reid; Donald B Calne; J K Greenacre; A Petrie; A N Bamji
Idiopathic parkinsonism treated with bromocriptine.
Lancet 1975;2(7933):473-6.
1975: P F Teychenne; Donald B Calne; P J Lewis; L J Findley
Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.
Clinical pharmacology and therapeutics 1975;18(3):273-7.
1975: Donald B Calne; L E Claveria; J L Reid
Hypothermic action of bromocriptine.
British journal of pharmacology 1975;54(1):123-4.
1975: L E Claveria; P F Teychenne; Donald B Calne; L Haskayne; A Petrie; C A Pallis; I C Lodge-Patch
Tardive dyskinesia treated with pimozide.
Journal of the neurological sciences 1975;24(4):393-401.
1975: M Sandler; L E Fellows; Donald B Calne; L J Findley
Letter: Oxprenolol and levodopa in parkinsonian patients.
Lancet 1975;1(7899):168.
1975: M J Aminoff; M Gross; B Laatz; S D Vakil; A Petrie; Donald B Calne
Arterial blood pressure in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1975;38(1):73-7.
1975: Donald B Calne
Drug treatment of spasticity and rigidity.
Modern trends in neurology 1975;6():205-21.
1975: L E Claveria; P F Teychenne; Donald B Calne; A Petrie; M F Bassendine
Dopaminergic agonists in Parkinsonism.
Advances in neurology 1975;9():383-92.
1974: Donald B Calne; P F Teychenne; P N Leigh; A N Bamji; J K Greenacre
Treatment of parkinsonism with bromocriptine.
Lancet 1974;2(7893):1355-6.
1974: Donald B Calne; P F Teychenne; L E Claveria; R Eastman; J K Greenacre; A Petrie
Bromocriptine in Parkinsonism.
British medical journal 1974;4(5942):442-4.
1974: P K Thomas; Donald B Calne; G Stewart
Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy).
Annals of human genetics 1974;38(2):111-53.
1974: M Sandler; R D Johnson; C R Ruthven; J L Reid; Donald B Calne
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
Nature 1974;247(440):364-6.
1974: P K Thomas; Donald B Calne
Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity.
Journal of neurology, neurosurgery, and psychiatry 1974;37(1):68-75.
1974: Donald B Calne; L E Claveria; P F Teychenne; L Haskayne; I C Lodge-Patch
Pimozide in tardive dyskinesia.
Transactions of the American Neurological Association 1974;99():166-70.
1973: L E Claveria; Donald B Calne; J G Allen
"On-off" phenomena related to high plasma levodopa.
British medical journal 1973;2(5867):641-3.
1973: Donald B Calne; J L Reid
Actions of levodopa on the blood pressure of conscious rabbits.
British journal of pharmacology 1973;48(2):194-7.
1973: Donald B Calne; J L Reid; S D Vakil
Parkinsonism treated with 3-O-methyldopa.
Clinical pharmacology and therapeutics 1973;14(3):386-9.
1973: Donald B Calne; J L Reid
Action of levodopa on the blood pressure of conscious rabbits.
Clinical science 1973;44(4):18P.
1973: D R Bevan; P S Monks; Donald B Calne
Cardiovascular reactions to anaesthesia during treatment with levodopa.
Anaesthesia 1973;28(1):29-31.
1972: J L Reid; Donald B Calne; C F George; S D Vakil
The action of L(-)-dopa on baroreflexes in Parkinsonism.
Clinical science 1972;43(6):851-9.
1972: Donald B Calne; C F George; J L Reid; S D Vakil
Changes in baroreflexes induced by L-dopa.
British journal of pharmacology 1972;46(3):539P.
1972: S K Rao; S D Vakil; Donald B Calne; A Hilson
Augmenting the action of levodopa.
Postgraduate medical journal 1972;48(565):653-6.
1972: J L Reid; Donald B Calne; C F George; S D Vakil
Circulatory effects of intravenous tyramine and noradrenalin in Parkinsonism.
The Journal of clinical pharmacology and new drugs 1972;12(11):465-71.
1972: J L Reid; Donald B Calne; S D Vakil; J G Allen; C A Davies
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
Journal of the neurological sciences 1972;17(1):45-51.
1972: J L Reid; Donald B Calne; C F George; S D Vakil
Levodopa and pressor amine sensitivity in parkinsonism.
Clinical pharmacology and therapeutics 1972;13(3):400-6.
1972: P K Thomas; Donald B Calne; C F Elliott
X-linked scapuloperoneal syndrome.
Journal of neurology, neurosurgery, and psychiatry 1972;35(2):208-15.
1972: Donald B Calne; A Petrie; S Rao; J L Reid; S D Vakil
Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
British journal of pharmacology 1972;44(1):162-4.
1972: P K Thomas; Donald B Calne; R H King
Autosomal dominant forms of hereditary hypertrophic neuropathy.
Monographs in human genetics 1972;6():210.
1972: Donald B Calne; J L Reid
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Drugs 1972;4(1):49-74.
1971: Donald B Calne
L-dopa and parkinsonism.
Nursing mirror and midwives journal 1971;133(15):26-7.
1971: J G Allen; Donald B Calne; C A Davies; J L Reid
Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim.
British journal of pharmacology 1971;43(2):464P-465P.
1971: Donald B Calne; J L Reid; S D Vakil; S Rao; A Petrie; C A Pallis; J Gawler; P K Thomas; A Hilson
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
British medical journal 1971;3(5777):729-32.
1971: J L Reid; Donald B Calne; C F George; C Pallis; S D Vakil
Cardiovascular reflexes in Parkinsonism.
Clinical science 1971;41(1):63-7.
1971: A S Spiers; Donald B Calne; S D Vakil; T M French
Action of thymoxamine on mydriasis induced by levodopa and dopamine.
British medical journal 1971;2(5759):438-9.
1971: J L Reid; Donald B Calne; C F George; S D Vakil
Cardiovascular reflex activity in Parkinsonism.
Clinical science 1971;40(2):6P-7P.
1970: C A Pallis; Donald B Calne
Parkinsonism and cardiac arrhythmias.
Lancet 1970;2(7686):1313.
1970: Donald B Calne
L-Dopa in the treatment of parkinsonism.
Clinical pharmacology and therapeutics 1970;11(6):789-801.
1970: Donald B Calne; D G Shaw; A S Spiers; G M Stern
Swallowing in Parkinsonism.
The British journal of radiology 1970;43(511):456-7.
1970: A S Spiers; Donald B Calne; P M Fayers
Miosis during L-dopa therapy.
British medical journal 1970;2(5710):639-40.
1970: Donald B Calne; T M French; A S Spiers
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man.
British journal of pharmacology 1970;39(1):195P-196P.
1970: Donald B Calne; M Sandler
L-Dopa and Parkinsonism.
Nature 1970;226(5240):21-4.
1970: Donald B Calne; J Brennan; A S Spiers; G M Stern
Hypotension caused by L-dopa.
British medical journal 1970;1(5694):474-5.
1969: M Sandler; F Karoum; C R Ruthven; Donald B Calne
m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.
Science (New York, N.Y.) 1969;166(3911):1417-8.
1969: A S Spiers; Donald B Calne
Action of dopamine on the human iris.
British medical journal 1969;4(5679):333-5.
1969: Donald B Calne; G M Stern; A S Spiers; D R Laurence
L-dopa in idiopathic parkinsonism.
Lancet 1969;2(7628):973-6.
1969: Donald B Calne; R A Webster
Tremor induced by tetrabenazine.
British journal of pharmacology 1969;37(2):468-75.
1969: Donald B Calne; F Karoum; C R Ruthven; M Sandler
The metabolism of orally administered L-Dopa in Parkinsonism.
British journal of pharmacology 1969;37(1):57-68.
1969: Donald B Calne; G M Stern; D R Laurence; J Sharkey; P Armitage
L-dopa in postencephalitic parkinsonism.
Lancet 1969;1(7598):744-6.
1969: Donald B Calne; M H Lader
Electromyographic studies of tremor using an averaging computer.
Electroencephalography and clinical neurophysiology 1969;26(1):86-92.
1968: Donald B Calne
Examination of the time relations of electrical activity in different muscle groups during tremor.
The Journal of physiology 1968;197(1):12P-14P.
1966: Donald B Calne; C A Pallis
Vibratory sense: a critical review.
Brain : a journal of neurology 1966;89(4):723-46.
1966: Donald B Calne; E B Raftery
Patent ductus arteriosus in an elderly man.
British heart journal 1966;28(5):716-7.
1966: Donald B Calne
Hypotension after exercise.
British medical journal 1966;1(5483):338-9.
1963: Donald B Calne; S LEIBOWITZ
Suppression of experimental allergic encephalomyelitis by cytotoxic drugs.
Nature 1963;197():1309-10.
1959: Donald B Calne
Pathways converging upon Purkinje cells in the frog's cerebellum.
The Journal of physiology 1959;146(3):459-64.